lamotrigine has been researched along with pramipexole in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fredman, SJ; Rosenbaum, JF | 1 |
Conn, DK; Mah, L | 1 |
El-Mallakh, RS; Elmaadawi, AZ; Gao, Y; Loganathan, M; Lohano, K | 1 |
Swartz, HA; Thase, ME | 1 |
3 review(s) available for lamotrigine and pramipexole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Bipolar disorder: an update.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzhydryl Compounds; Benzothiazoles; Bipolar Disorder; Diagnosis, Differential; Dibenzothiazepines; Dopamine Agonists; Humans; Lamotrigine; Modafinil; Pramipexole; Prognosis; Psychotherapy; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Triazines | 2010 |
Pharmacotherapy for the treatment of acute bipolar II depression: current evidence.
Topics: Acute Disease; Antidepressive Agents; Antimanic Agents; Benzhydryl Compounds; Benzothiazoles; Bipolar Disorder; Dibenzothiazepines; Humans; Lamotrigine; Lithium Compounds; Modafinil; Pramipexole; Quetiapine Fumarate; Triazines | 2011 |
4 other study(ies) available for lamotrigine and pramipexole
Article | Year |
---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pramipexole treatment for cocaine cravings.
Topics: Adult; Antidepressive Agents; Behavior, Addictive; Benzothiazoles; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Diagnosis, Dual (Psychiatry); Dopamine Agonists; Drug Therapy, Combination; Humans; Lamotrigine; Male; Pramipexole; Thiazoles; Treatment Outcome; Triazines | 1999 |
Use of the D2/D3 receptor agonist pramipexole in treatment of rapid-cycling bipolar disorder in an elderly patient.
Topics: Aged; Anticonvulsants; Antidepressive Agents, Second-Generation; Benzothiazoles; Bipolar Disorder; Bupropion; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lamotrigine; Pramipexole; Triazines | 2010 |